Clusterin induces CXCR4 expression and migration of cardiac progenitor cells

Experimental Cell Research

Volumn 316, Issue 20, 2010, Pages 3435-3442

  Li, Yangxin ^a   Qu, Jiangbo ^a,b   Shelat, Harnath ^c   Gao, Song ^a   Wassler, Michael ^c   Geng, Yong Jian ^a,c  

^a ST LUKE S EPISCOPAL HOSPITAL   (United States)

^b SHANDONG UNIVERSITY   (China)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Cardiac progenitor cell; Chemokine; Clusterin; High density lipoprotein; Migration

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; CHEMOKINE RECEPTOR CXCR4; CLUSTERIN; COMPLEMENTARY DNA; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL HOMING; CELL ISOLATION; CELL MIGRATION; CELL STIMULATION; CONTROLLED STUDY; FETUS; FLOW CYTOMETRY; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; HEART MUSCLE CELL; HEART PROGENITOR CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL;

EID: 78149412644     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2010.08.012     Document Type: Article

References (45)

1. Tillmanns J., Rota M., Hosoda T., Misao Y., Esposito G., Gonzalez A., Vitale S., Parolin C., Yasuzawa-Amano S., Muraski J., De Angelis A., Lecapitaine N., Siggins R.W., Loredo M., Bearzi C., Bolli R., Urbanek K., Leri A., Kajstura J., Anversa P. Formation of large coronary arteries by cardiac progenitor cells. Proc. Natl Acad. Sci. USA 2008, 105:1668-1673.
2. Kim H., Kim S.W., Nam D., Kim S., Yoon Y.S. Cell therapy with bone marrow cells for myocardial regeneration. Antioxid. Redox Signal. 2009, 11:1897-1911.
3. Iso Y., Spees J.L., Serrano C., Bakondi B., Pochampally R., Song Y.H., Sobel B.E., Delafontaine P., Prockop D.J. Multipotent human stromal cells improve cardiac function after myocardial infarction in mice without long-term engraftment. Biochem. Biophys. Res. Commun. 2007, 354:700-706.
4. Linke A., Muller P., Nurzynska D., Casarsa C., Torella D., Nascimbene A., Castaldo C., Cascapera S., Bohm M., Quaini F., Urbanek K., Leri A., Hintze T.H., Kajstura J., Anversa P. Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc. Natl Acad. Sci. USA 2005, 102:8966-8971.
5. Vogel G. Cell biology. Stem cells: new excitement, persistent questions. Science 2000, 290:1672-1674.
6. Wagers A.J., Weissman I.L. Plasticity of adult stem cells. Cell 2004, 116:639-648.
7. Nagasawa T., Hirota S., Tachibana K., Takakura N., Nishikawa S., Kitamura Y., Yoshida N., Kikutani H., Kishimoto T. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 1996, 382:635-638.
8. Zou Y.R., Kottmann A.H., Kuroda M., Taniuchi I., Littman D.R. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 1998, 393:595-599.
9. Peled A., Petit I., Kollet O., Magid M., Ponomaryov T., Byk T., Nagler A., Ben-Hur H., Many A., Shultz L., Lider O., Alon R., Zipori D., Lapidot T. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 1999, 283:845-848.
10. Hung S.C., Pochampally R.R., Hsu S.C., Sanchez C., Chen S.C., Spees J., Prockop D.J. Short-term exposure of multipotent stromal cells to low oxygen increases their expression of CX3CR1 and CXCR4 and their engraftment in vivo. PLoS ONE 2007, 2:e416.
11. Barbero S., Bonavia R., Bajetto A., Porcile C., Pirani P., Ravetti J.L., Zona G.L., Spaziante R., Florio T., Schettini G. Stromal cell-derived factor 1alpha stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and Akt. Cancer Res. 2003, 63:1969-1974.
12. Peng S.B., Peek V., Zhai Y., Paul D.C., Lou Q., Xia X., Eessalu T., Kohn W., Tang S. Akt activation, but not extracellular signal-regulated kinase activation, is required for SDF-1alpha/CXCR4-mediated migration of epitheloid carcinoma cells. Mol. Cancer Res. 2005, 3:227-236.
13. Wang J.F., Park I.W., Groopman J.E. Stromal cell-derived factor-1alpha stimulates tyrosine phosphorylation of multiple focal adhesion proteins and induces migration of hematopoietic progenitor cells: roles of phosphoinositide-3 kinase and protein kinase C. Blood 2000, 95:2505-2513.
14. de Silva H.V., Stuart W.D., Duvic C.R., Wetterau J.R., Ray M.J., Ferguson D.G., Albers H.W., Smith W.R., Harmony J.A. A 70-kDa apolipoprotein designated ApoJ is a marker for subclasses of human plasma high density lipoproteins. J. Biol. Chem. 1990, 265:13240-13247.
15. Wilson M.R., Easterbrook-Smith S.B. Clusterin is a secreted mammalian chaperone. Trends Biochem. Sci. 2000, 25:95-98.
16. Rosenberg M.E., Girton R., Finkel D., Chmielewski D., Barrie A., Witte D.P., Zhu G., Bissler J.J., Harmony J.A., Aronow B.J. Apolipoprotein J/clusterin prevents a progressive glomerulopathy of aging. Mol. Cell. Biol. 2002, 22:1893-1902.
17. Negre-Salvayre A., Dousset N., Ferretti G., Bacchetti T., Curatola G., Salvayre R. Antioxidant and cytoprotective properties of high-density lipoproteins in vascular cells. Free Radic. Biol. Med. 2006, 41:1031-1040.
18. Ishikawa Y., Akasaka Y., Ishii T., Komiyama K., Masuda S., Asuwa N., Choi-Miura N.H., Tomita M. Distribution and synthesis of apolipoprotein J in the atherosclerotic aorta. Arterioscler. Thromb. Vasc. Biol. 1998, 18:665-672.
19. Miyata M., Biro S., Kaieda H., Eto H., Orihara K., Kihara T., Obata H., Matsushita N., Matsuyama T., Tei C. Apolipoprotein J/clusterin is induced in vascular smooth muscle cells after vascular injury. Circulation 2001, 104:1407-1412.
20. Trougakos I.P., Poulakou M., Stathatos M., Chalikia A., Melidonis A., Gonos E.S. Serum levels of the senescence biomarker clusterin/apolipoprotein J increase significantly in diabetes type II and during development of coronary heart disease or at myocardial infarction. Exp. Gerontol. 2002, 37:1175-1187.
21. McLaughlin L., Zhu G., Mistry M., Ley-Ebert C., Stuart W.D., Florio C.J., Groen P.A., Witt S.A., Kimball T.R., Witte D.P., Harmony J.A., Aronow B.J. Apolipoprotein J/clusterin limits the severity of murine autoimmune myocarditis. J. Clin. Invest. 2000, 106:1105-1113.
22. Swertfeger D.K., Witte D.P., Stuart W.D., Rockman H.A., Harmony J.A. Apolipoprotein J/clusterin induction in myocarditis: a localized response gene to myocardial injury. Am. J. Pathol. 1996, 148:1971-1983.
23. Dumont P., Chainiaux F., Eliaers F., Petropoulou C., Remacle J., Koch-Brandt C., Gonos E.S., Toussaint O. Overexpression of apolipoprotein J in human fibroblasts protects against cytotoxicity and premature senescence induced by ethanol and tert-butylhydroperoxide. Cell Stress Chaperones 2002, 7:23-35.
24. Nofer J.R., Levkau B., Wolinska I., Junker R., Fobker M., von Eckardstein A., Seedorf U., Assmann G. Suppression of endothelial cell apoptosis by high density lipoproteins (HDL) and HDL-associated lysosphingolipids. J. Biol. Chem. 2001, 276:34480-34485.
25. Krijnen P.A., Cillessen S.A., Manoe R., Muller A., Visser C.A., Meijer C.J., Musters R.J., Hack C.E., Aarden L.A., Niessen H.W. Clusterin: a protective mediator for ischemic cardiomyocytes?. Am. J. Physiol. Heart Circ. Physiol. 2005, 289:H2193-H2202.
26. Sivamurthy N., Stone D.H., Logerfo F.W., Quist W.C. Apolipoprotein J inhibits the migration, adhesion, and proliferation of vascular smooth muscle cells. J. Vasc. Surg. 2001, 34:716-723.
27. Sivamurthy N., Stone D.H., LoGerfo F.W., Quist W.C. Apolipoprotein J inhibits the migration and adhesion of endothelial cells. Surgery 2001, 130:204-209.
28. Castelli W.P., Garrison R.J., Wilson P.W., Abbott R.D., Kalousdian S., Kannel W.B. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. Jama 1986, 256:2835-2838.
29. Franceschini G. Epidemiologic evidence for high-density lipoprotein cholesterol as a risk factor for coronary artery disease. Am. J. Cardiol. 2001, 88:9N-13N.
30. Tso C., Martinic G., Fan W.H., Rogers C., Rye K.A., Barter P.J. High-density lipoproteins enhance progenitor-mediated endothelium repair in mice. Arterioscler. Thromb. Vasc. Biol. 2006, 26:1144-1149.
31. Viswambharan H., Ming X.F., Zhu S., Hubsch A., Lerch P., Vergeres G., Rusconi S., Yang Z. Reconstituted high-density lipoprotein inhibits thrombin-induced endothelial tissue factor expression through inhibition of RhoA and stimulation of phosphatidylinositol 3-kinase but not Akt/endothelial nitric oxide synthase. Circ. Res. 2004, 94:918-925.
32. DeKroon R., Robinette J.B., Hjelmeland A.B., Wiggins E., Blackwell M., Mihovilovic M., Fujii M., York J., Hart J., Kontos C., Rich J., Strittmatter W.J. APOE4-VLDL inhibits the HDL-activated phosphatidylinositol 3-kinase/Akt pathway via the phosphoinositol phosphatase SHIP2. Circ. Res. 2006, 99:829-836.
33. Norata G.D., Callegari E., Marchesi M., Chiesa G., Eriksson P., Catapano A.L. High-density lipoproteins induce transforming growth factor-beta2 expression in endothelial cells. Circulation 2005, 111:2805-2811.
34. Mineo C., Yuhanna I.S., Quon M.J., Shaul P.W. High density lipoprotein-induced endothelial nitric-oxide synthase activation is mediated by Akt and MAP kinases. J. Biol. Chem. 2003, 278:9142-9149.
35. Kimura T., Sato K., Malchinkhuu E., Tomura H., Tamama K., Kuwabara A., Murakami M., Okajima F. High-density lipoprotein stimulates endothelial cell migration and survival through sphingosine 1-phosphate and its receptors. Arterioscler. Thromb. Vasc. Biol. 2003, 23:1283-1288.
36. Li Y., Sagar M.B., Wassler M., Shelat H., Geng Y.J. Apolipoprotein-J prevention of fetal cardiac myoblast apoptosis induced by ethanol. Biochem. Biophys. Res. Commun. 2007, 357:157-161.
37. Madonna R., Shelat H., Xue Q., Willerson J.T., De Caterina R., Geng Y.J. Erythropoietin protects myocardin-expressing cardiac stem cells against cytotoxicity of tumor necrosis factor-alpha. Exp. Cell Res. 2009, 315:2921-2928.
38. Ji J.F., He B.P., Dheen S.T., Tay S.S. Interactions of chemokines and chemokine receptors mediate the migration of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury. Stem Cells 2004, 22:415-427.
39. Odemis V., Boosmann K., Dieterlen M.T., Engele J. The chemokine SDF1 controls multiple steps of myogenesis through atypical PKC{zeta}. J. Cell Sci. 2007, 120:4050-4059.
40. Porecha N.K., English K., Hangoc G., Broxmeyer H.E., Christopherson K.W. Enhanced functional response to CXCL12/SDF-1 through retroviral overexpression of CXCR4 on M07e cells: implications for hematopoietic stem cell transplantation. Stem Cells Dev. 2006, 15:325-333.
41. +progenitor cells. J. Clin. Invest. 2005, 115:168-176.
42. Lee R.H., Hsu S.C., Munoz J., Jung J.S., Lee N.R., Pochampally R., Prockop D.J. A subset of human rapidly self-renewing marrow stromal cells preferentially engraft in mice. Blood 2006, 107:2153-2161.
43. Orschell-Traycoff C.M., Hiatt K., Dagher R.N., Rice S., Yoder M.C., Srour E.F. Homing and engraftment potential of Sca-1(+)lin(-) cells fractionated on the basis of adhesion molecule expression and position in cell cycle. Blood 2000, 96:1380-1387.
44. Szilvassy S.J., Meyerrose T.E., Grimes B. Effects of cell cycle activation on the short-term engraftment properties of ex vivo expanded murine hematopoietic cells. Blood 2000, 95:2829-2837.
45. Petropoulou C., Trougakos I.P., Kolettas E., Toussaint O., Gonos E.S. Clusterin/apolipoprotein J is a novel biomarker of cellular senescence that does not affect the proliferative capacity of human diploid fibroblasts. FEBS Lett. 2001, 509:287-297.